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BRCC36
Ins-1 His94Gln, Ser95Ser, His96Gln (QSQ) mutant in pink. Zoom-in panel shows active site details.
The structure of the bound KIAA0157 subunit has been omitted for clarity. heterodimer. E-loop (BRCC36) and the KIAA0157-specific E-loop supporting element are labeled. KIAA0157 possesses an insert (denoted the E-loop supporting element) not present in BRCC36 that buttresses a productive conformation of the E-loop of BRCC36.
B)
Multiple sequence alignment (black = conserved, white = not conserved) of BRCC36 and KIAA0157 (KIAA) from the indicated species. Alignments were performed with MUSCLE and edited and displayed using ALINE. The secondary structure of BRCC36 (blue) and KIAA0157
(green) determined by DSSP is shown above and below the alignment. The ant BRCC36 and KIAA0157 sequences are numbered at the top and bottom of the alignment respectively. Cf, C. Figure 5C . E) Size exclusion chromatography followed by multi angle light scattering (SEC-MALS)
analysis of the indicated BRCC36-KIAA0157 mutant complexes analyzed in Figure 5C . G) Coomassie-stained SDS-PAGE analysis of the indicated CfBRCC36-KIAA0157ΔC complexes. 
SUPPLEMENTAL TABLES
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Cloning, protein expression and purification of CfBRCC36-KIAA0157ΔC complex All proteins and complexes described here were produced using the Multibac baculovirus/insect cell system (ATG biosynthetics). Full-length CfBRCC36 (or mutants thereof) preceded by a 6-His purification tag and TEV cleavage sequence was cloned into a pACEBac-1 expression vector. Tag-less CfKIAA0157ΔC (or mutants thereof) was cloned in the same pACEBac-1 vector (containing 6-His-TEV-BRCC36) using the manufacturer's protocol. Bacmid DNA was generated in DH10MultiBac-Turbo cells (ATG Biosynthetics) following manufacturer's protocol, and virus amplification and cell expression in Sf9 cells was carried out using standard procedures. Cells were harvested by centrifugation for 15 min at 500 g and resuspended in icecold lysis buffer. Cells were lysed using an Avestin C3 cell disrupter (18,000 psi), and lysate was cleared by centrifugation at 30,000 g for 30 min and filtration using a 0.45 µm filter, before loading onto a 5 ml HiTrap IMAC HP column (GE Healthcare, USA). After washing with 10 column volumes (CV) of high salt wash buffer B, the complex was eluted with a gradient of 20-300 mM imidazole. Fractions containing the complex were pooled and 0.3-0.5 mg of His-tagged TEV protease was added prior to dialysis against 4 l of wash buffer A for 12-14 h. The TEV protease and non-cleaved His-CfBRCC36 were removed by subtraction on HiTrap IMAC resin.
The cleaved protein was concentrated and resolved on a Sepharose-S200 16/60 column (GE Healthcare, USA), pre-equilibrated in 25 mM HEPES-Na pH 7.0, 150 mM NaCl and 5 mM DTT.
Eluted peaks were analyzed by SDS-PAGE, and fractions containing >95% pure CfBRCC36-CfKIAA0157ΔC complex were combined, concentrated to 7-10 mg/ml, snap-frozen in liquid nitrogen and stored at -80 o C.
CfBRISCΔNΔC, DrBRISCΔNΔC, and the CfBRCC36-KIA0157ΔC-BRCC45 subcomplex, were cloned, expressed and purified as described for the CfBRCC36-KIAA0157ΔC subcomplex by exploiting a single poly-His tag fused to BRCC36. Cloning, protein expression and purification of HsBRISC, HsARISCΔN, and CfBRCC45-MERIT40ΔN, exploited the single poly-His tag fused to the BRCC45 subunit and were produced as described for the CfBRCC36-KIAA0157
complex.
Cloning, protein expression and purification of DrBRCC36 (residues 1-260) was essentially as described for CfBRCC36 above, without co-expression with KIAA0157.
Production of selenomethionine-substituted CfBRCC36-KIAA0157ΔC complex
Sf9 cells grown in suspension were first conditioned in methionine-free media by splitting 1:3 for two passages in ESF921ΔMet medium (Expression Systems, USA). The culture was split to 8 × 10 5 in methionine-free media and after 24 hours was infected with 1/15 of P2 virus. DLselenomethionine was added 8 hours after infection at 100 mg/l, followed by a second addition at 24 hours. Cells were harvested 48 hours after infection and selenomethionine-substituted BRCC36-KIAA0157ΔC complex was purified as described above. Selenomethionine incorporation was verified (~60%) by mass spectrometry. Data were collected at 100 K on station 24-ID-C, NE CAT beamline, Advanced Photon Source (APS) and processed using the XDS package (Kabsch, 2010) (see Table 1 for data collection and refinement statistics). The structure was solved using the SHELX programing suite ( 
Small angle X-ray Scattering (SAXS) analysis
The CfBRCC36-KIAA0157ΔC complex was resolved over a Superdex-200 (GE Healthcare) size exclusion chromatography column and sample homogeneity was confirmed by dynamic light scattering. The X-ray scattering data were collected on a BioSAXS-1000 configured on the right port of a MicroMax-007HF X-ray generator using a 35 µl sample volume. Consecutive scans of 10, 15 and 60 minutes were collected at 10 °C for three different protein concentrations (3, 7.5
and 15 mg/ml). To generate the sample scattering curves, SAXSLab 3.0.0r1 software (Rigaku) was used to subtract buffer scattering from the protein scattering. SAXS profiles at the three concentrations were analyzed using the ATSAS program suite v.2.5.1 (Konarev et al., 2006) .
None of the samples showed interparticle interactions and they appeared to be folded as judged by the Kratky plot. The highest quality estimates determined from the Guinier plot and pairdistance distribution function were used to select the sample used for further processing (7.5 mg/ml and 60 minutes exposure time). The CfBRCC36-KIAA0157ΔC complex had a radius of gyration (Rg) of 40.8 ± 0.1 Å and Dmax of 138 Å using 0.008 < s < 0.3 range. Ten ab initio models were generated using DAMMIF (Franke and Svergun, 2009 ) and averaged using DAMAVER (Volkov and Svergun, 2003) . The model was refined with DAMMIN (Svergun, 1999 ) using the damstart.pdb file as the starting search volume. Theoretical scattering curves for the possible super dimers were generated and compared to the experimental scattering curves using CRYSOL (Svergun et al., 1995) .
SEC-MALS analysis
BRCC36-containing complexes were analyzed using a SEC-MALS apparatus equipped with MiniDawn Treos and Optilab T-rEX detectors (Wyatt technologies, USA). Samples were run in a buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl and 1 mM TCEP and flow rate of 0.5 ml/min. C. floridanus proteins were run on a WTC015S5 (Wyatt technologies, USA) column at a concentration of 1 mg/ml. D. rerio and H. sapiens proteins were run on a WTC050S5 column (Wyatt technologies, USA) at the following concentrations: DrBRCC36, 0.8 mg/ml; DrBRISCΔNΔC, 0.25 mg/ml; HsBRISCΔNΔC , 0.1 mg/ml and HsARISCΔN, 0.25 mg/ml. Data was processed using Astra 6.0.3.16 Software (Wyatt technologies, USA).
DUB activity assays
WT and mutant forms of BRCC36-containing complexes were assayed at 30 o C in DUB reaction buffer containing 50 mM HEPES-NaOH pH 7.0, 100 mM NaCl, 1 mg/ml BSA, constrained to the calculated value from low substrate concentrations (up to 2.5 µM), for which the kinetics follow simple Michaelis-Menten behavior.
Native mass spectrometry measurements for HsBRISC
Full length HsBRISC was buffer exchanged sequentially into 100 mM aqueous ammonium acetate pH 6.8 buffer using centrifugal filter units with a cut-off of 50 kDa (Millipore, England).
The HsBRISC concentration used for the mass spectrometry measurements was ~1 µM (assuming intact protein complexes). Instrumentation used and corresponding settings and procedures were described by (Koschubs et al., 2010) .
Generation of fluorophore-conjugated K63-linked diUb
A K63-linked diUb chain with a reactive thiol group at the C-terminus of the proximal ubiquitin was generated using the procedure of Pickart and Raasi (Pickart and Raasi, 2005) with one modification. In place of ubiquitin D77, ubiquitin harboring an R75C mutation and lacking the last two glycine residues was used in the enzymatic reaction. 0.2 mM purified diUb chains were then labeled in 0.1 ml reaction volumes in buffer containing 25 mM HEPES-Na (pH 7.5), 100 mM NaCl and 0.5 mM TCEP, and stepwise addition of Alexa Fluor 488 C5 maleimide (Invitrogen) to a final 0.6 mM concentration. Reactions were carried out overnight in the dark at room temperature and were stopped by addition of 6 mM reduced glutathione. Free dye was removed using 2 ml Zebra TM desalting columns (ThermoFisher). Labeling efficiency was assessed by mass spectrometry at 64%.
Fluorescence polarization binding assays
Binding reactions were performed with 10 nM fluorophore-conjugated K63-linked diUb and the indicated protein concentrations in fluorescence polarization (FP) buffer consisting of 50 mM HEPES-NaOH pH 7.5, 100 mM NaCl, 1 mM TCEP, 0.03% Brij-35 and 1 mg/ml BSA. Binding 
